AU1884497A - New associations of active principles containing clopidogrel and an antithrombotic agent - Google Patents
New associations of active principles containing clopidogrel and an antithrombotic agentInfo
- Publication number
- AU1884497A AU1884497A AU18844/97A AU1884497A AU1884497A AU 1884497 A AU1884497 A AU 1884497A AU 18844/97 A AU18844/97 A AU 18844/97A AU 1884497 A AU1884497 A AU 1884497A AU 1884497 A AU1884497 A AU 1884497A
- Authority
- AU
- Australia
- Prior art keywords
- active principles
- pct
- antithrombotic agent
- new associations
- containing clopidogrel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
PCT No. PCT/FR97/00296 Sec. 371 Date Aug. 12, 1998 Sec. 102(e) Date Aug. 12, 1998 PCT Filed Feb. 17, 1997 PCT Pub. No. WO97/29753 PCT Pub. Date Aug. 21, 1997The invention relates to a pharmaceutical composition containing an association of active principles, wherein the active principles are clopidogrel and aspirin, each constituent being present in a free form or in the form of a pharmaceutically acceptable salt.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9602027A FR2744918B1 (en) | 1996-02-19 | 1996-02-19 | NEW COMBINATIONS OF ACTIVE INGREDIENTS CONTAINING THIENO (3,2-C) PYRIDINE DERIVATIVE AND AN ANTITHROMBOTIC |
FR96/02027 | 1996-02-19 | ||
PCT/FR1997/000296 WO1997029753A1 (en) | 1996-02-19 | 1997-02-17 | New associations of active principles containing clopidogrel and an antithrombotic agent |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1884497A true AU1884497A (en) | 1997-09-02 |
AU715655B2 AU715655B2 (en) | 2000-02-10 |
Family
ID=9489354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18844/97A Revoked AU715655B2 (en) | 1996-02-19 | 1997-02-17 | New associations of active principles containing clopidogrel and an antithrombotic agent |
Country Status (29)
Country | Link |
---|---|
US (1) | US5989578A (en) |
EP (1) | EP0881901B1 (en) |
JP (1) | JP3662028B2 (en) |
KR (1) | KR100295345B1 (en) |
CN (1) | CN1116042C (en) |
AT (1) | ATE218870T1 (en) |
AU (1) | AU715655B2 (en) |
BR (1) | BR9707556A (en) |
CA (1) | CA2246289C (en) |
CZ (1) | CZ292363B6 (en) |
DE (2) | DE69713287T2 (en) |
DK (1) | DK0881901T3 (en) |
EE (1) | EE03513B1 (en) |
ES (1) | ES2176684T3 (en) |
FR (1) | FR2744918B1 (en) |
HK (1) | HK1017850A1 (en) |
HU (1) | HU225036B1 (en) |
IL (1) | IL125848A (en) |
IS (1) | IS1892B (en) |
NO (2) | NO317747B3 (en) |
NZ (1) | NZ331444A (en) |
PL (1) | PL187292B1 (en) |
PT (1) | PT881901E (en) |
RU (1) | RU2184547C2 (en) |
SI (1) | SI0881901T1 (en) |
SK (1) | SK284285B6 (en) |
TR (1) | TR199801608T2 (en) |
UA (1) | UA51695C2 (en) |
WO (1) | WO1997029753A1 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1061908A4 (en) * | 1998-03-13 | 2007-01-24 | Merck & Co Inc | Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
ATE302012T1 (en) | 1998-06-17 | 2005-09-15 | Bristol Myers Squibb Co | PREVENTION OF BRAIN INFARCTION THROUGH COMBINED ADMINISTRATION OF ADP RECEPTOR ANTILPLATETS AND ANTIHYPERTENSIVE DRUGS |
US6509348B1 (en) | 1998-11-03 | 2003-01-21 | Bristol-Myers Squibb Company | Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination |
FR2792836B3 (en) | 1999-04-30 | 2001-07-27 | Sanofi Sa | PHARMACEUTICAL COMPOSITION IN UNIT FORM CONTAINING ASPIRIN AND CLOPIDOGREL HYDROGENOSULFATE |
FR2797400A1 (en) * | 1999-08-11 | 2001-02-16 | Sanofi Synthelabo | ASSOCIATIONS WITH ANTI-THROMBOTIC ACTIVITY COMPRISING CLOPIDOGREL HYDROGENOSULFATE AND A GPIIB / IIIA RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
ES2311498T3 (en) * | 2000-12-25 | 2009-02-16 | Daiichi Sankyo Company, Limited | MEDICINAL COMPOSITIONS CONTAINING ASPIRINE. |
SE0101932D0 (en) * | 2001-05-31 | 2001-05-31 | Astrazeneca Ab | Pharmaceutical combinations |
FR2832929A1 (en) * | 2001-12-05 | 2003-06-06 | Sanofi Synthelabo | Composition used for treating disorders due to platelet aggregation e.g. unstable angina and stroke, contains antithrombotic agent and cyclic amine derivative |
WO2004031143A2 (en) * | 2002-10-02 | 2004-04-15 | Bristol-Myers Squibb Company | Novel combination of a factor xa inhibitor and clopidogrel |
US20070243632A1 (en) * | 2003-07-08 | 2007-10-18 | Coller Barry S | Methods for measuring platelet reactivity of patients that have received drug eluting stents |
WO2005007868A2 (en) * | 2003-07-08 | 2005-01-27 | Accumetrics, Inc. | Controlled platelet activation to monitor therapy of adp antagonists |
HUP0400982A2 (en) * | 2004-05-17 | 2006-08-28 | Chemor Kutato | New veterinary product for honeybees |
US20060222640A1 (en) * | 2005-03-29 | 2006-10-05 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for treatment of thrombosis |
EP1926736A4 (en) * | 2005-09-21 | 2010-08-25 | Chong Kun Dang Pharm Corp | Novel resinate complex of s-clopidogrel and production method thereof |
WO2008048083A1 (en) * | 2006-10-17 | 2008-04-24 | Espinosa Abdala Leopoldo De Je | Pharmaceutical compositions for the treatment of thromboembolic diseases |
DE102006051625A1 (en) | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Combination therapy of substituted oxazolidinones |
NZ581362A (en) * | 2007-04-27 | 2011-07-29 | Cydex Pharmaceuticals Inc | Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
KR100949273B1 (en) * | 2008-02-22 | 2010-03-25 | 한올제약주식회사 | Combined Formulation |
DE102008032361A1 (en) * | 2008-07-10 | 2010-01-21 | Csl Behring Gmbh | The use of factor VIII and vWF or vWF-containing concentrates for the therapy of thrombocyte inhibitors induced coagulopathy |
HUE047755T2 (en) * | 2009-05-13 | 2020-05-28 | Cydex Pharmaceuticals Inc | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
KR20120050437A (en) | 2009-06-25 | 2012-05-18 | 테트라, 시아 | Novel acetylsalicylic acid salts |
US8563574B2 (en) | 2009-12-07 | 2013-10-22 | Academic Pharmaceuticals, Inc. | Parenteral formulation of clopidogrel |
CN102389436A (en) * | 2011-09-09 | 2012-03-28 | 北京阜康仁生物制药科技有限公司 | Medicinal composition for resisting platelet aggregation |
KR101675501B1 (en) * | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | Combination of Clopidogrel and Aspirin |
US8513278B2 (en) | 2011-11-26 | 2013-08-20 | Academic Pharmaceuticals, Inc. | Parenteral dextrose formulation of clopidogrel |
CN102406938A (en) * | 2011-11-29 | 2012-04-11 | 北京阜康仁生物制药科技有限公司 | Medicine composition for resisting thrombosis |
WO2013133620A1 (en) * | 2012-03-09 | 2013-09-12 | Yuhan Corporation | Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same |
CN103720700A (en) * | 2012-10-10 | 2014-04-16 | 江苏威凯尔医药科技有限公司 | Medical composition containing aspirin and vicagrel |
ES2657291T3 (en) | 2013-04-22 | 2018-03-02 | Csl Ltd. | A covalent complex of von Willebrand factor and factor VIII associated by a disulfide bridge |
KR101502588B1 (en) | 2013-05-01 | 2015-03-16 | 한국유나이티드제약 주식회사 | Combination of Clopidogrel and Aspirin |
JP5905165B2 (en) * | 2013-08-02 | 2016-04-20 | サノフイ | Pharmaceutical tablets containing acetylsalicylic acid and clopidogrel |
HUP1400294A2 (en) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Novel application of clopidogrel |
CN107698620A (en) * | 2015-06-23 | 2018-02-16 | 江苏天士力帝益药业有限公司 | A kind of deuterated thieno piperidine derivative, preparation method and applications |
RU2745774C1 (en) * | 2020-08-14 | 2021-03-31 | Алексей Викторович Марочков | Method for treatment of patients with new coronavirus infection (covid-19) |
US20230059869A1 (en) | 2021-08-03 | 2023-02-23 | Liqmeds Worldwide Limited | Oral pharmaceutical solution of clopidogrel |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2307538A1 (en) * | 1975-04-18 | 1976-11-12 | Centre Etd Ind Pharma | NEW PLATELET ANTI-AGGREGANT DRUG |
-
1996
- 1996-02-19 FR FR9602027A patent/FR2744918B1/en not_active Expired - Fee Related
-
1997
- 1997-02-17 CA CA002246289A patent/CA2246289C/en not_active Expired - Lifetime
- 1997-02-17 UA UA98094800A patent/UA51695C2/en unknown
- 1997-02-17 DE DE69713287T patent/DE69713287T2/en not_active Expired - Lifetime
- 1997-02-17 IL IL12584897A patent/IL125848A/en not_active IP Right Cessation
- 1997-02-17 ES ES97905218T patent/ES2176684T3/en not_active Expired - Lifetime
- 1997-02-17 SK SK1105-98A patent/SK284285B6/en not_active IP Right Cessation
- 1997-02-17 NZ NZ331444A patent/NZ331444A/en not_active IP Right Cessation
- 1997-02-17 WO PCT/FR1997/000296 patent/WO1997029753A1/en active IP Right Grant
- 1997-02-17 HU HU9901144A patent/HU225036B1/en active Protection Beyond IP Right Term
- 1997-02-17 PL PL97327923A patent/PL187292B1/en unknown
- 1997-02-17 KR KR1019980706556A patent/KR100295345B1/en not_active IP Right Cessation
- 1997-02-17 US US09/117,904 patent/US5989578A/en not_active Expired - Lifetime
- 1997-02-17 RU RU98117511/14A patent/RU2184547C2/en active
- 1997-02-17 EP EP97905218A patent/EP0881901B1/en not_active Expired - Lifetime
- 1997-02-17 JP JP52906097A patent/JP3662028B2/en not_active Expired - Lifetime
- 1997-02-17 DK DK97905218T patent/DK0881901T3/en active
- 1997-02-17 CN CN97192393A patent/CN1116042C/en not_active Expired - Lifetime
- 1997-02-17 SI SI9730355T patent/SI0881901T1/en unknown
- 1997-02-17 EE EE9800247A patent/EE03513B1/en not_active IP Right Cessation
- 1997-02-17 PT PT97905218T patent/PT881901E/en unknown
- 1997-02-17 TR TR1998/01608T patent/TR199801608T2/en unknown
- 1997-02-17 DE DE201012000030 patent/DE122010000030I2/en active Active
- 1997-02-17 BR BR9707556A patent/BR9707556A/en not_active IP Right Cessation
- 1997-02-17 AU AU18844/97A patent/AU715655B2/en not_active Revoked
- 1997-02-17 CZ CZ19982499A patent/CZ292363B6/en not_active IP Right Cessation
- 1997-02-17 AT AT97905218T patent/ATE218870T1/en active
-
1998
- 1998-08-18 IS IS4827A patent/IS1892B/en unknown
- 1998-08-19 NO NO19983812A patent/NO317747B3/en not_active IP Right Cessation
-
1999
- 1999-07-08 HK HK99102920A patent/HK1017850A1/en not_active IP Right Cessation
-
2010
- 2010-07-09 NO NO2010015C patent/NO2010015I2/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1884497A (en) | New associations of active principles containing clopidogrel and an antithrombotic agent | |
CA2177772A1 (en) | Pharmaceutical compositions containing irbesartan | |
CA2180816A1 (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
HUP9801880A3 (en) | Novel cryptophycins, their use and pharmaceutical compositions containing them | |
AU1031697A (en) | Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions | |
AU6850094A (en) | Novel hydroxybiphenyl derivatives, their preparation and pharmaceutical compositions containing same | |
AU6633596A (en) | Improved therapeutic agents | |
MX9708394A (en) | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation. | |
GEP20063719B (en) | Prevention of Migraine Recurrence | |
IL110724A0 (en) | Retroviral protease inhibitors, their preparation and pharmaceutical compositions containing them | |
PL316079A1 (en) | Antiussive composition containing an antitussive agent and benzidamine | |
MX9709453A (en) | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form. | |
BG106151A (en) | Pharmaceutical complex | |
GB9802542D0 (en) | New use | |
AU7533394A (en) | Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel | |
AU1867497A (en) | New quinoxalindione derivatives, their production and use in pharmaceutical agents | |
TW333453B (en) | Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases | |
AU8430791A (en) | Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them | |
AU688438C (en) | New pyridazino(4',5':3,4)pyrrolo-(2,1-A)isoquinolines and their use for preparing pharmaceutical compositions | |
AU1314395A (en) | New pyridazino(4',5':3,4)pyrrolo-(2,1-A)isoquinolines and their use for preparing pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TC | Change of applicant's name (sec. 104) |
Owner name: SANOFI- SYNTHELABO Free format text: FORMER NAME: SANOFI |
|
FGA | Letters patent sealed or granted (standard patent) |